◼ Archived
Business
New Type of Blood Thinner Approved to Prevent Repeat Strokes
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.
1 trends tracked about this subject — the full history, oldest to newest below.
The FDA has approved Bayer's asundexian, a first-in-class Factor XI inhibitor, to prevent recurrent strokes in a decision covered by eight major outlets.